Comparative evaluation of five aminoglycosides for treatment. 1976

H Rosin, and P Naumann, and E Reintjens, and M Köhler

Gentamicin, tobramycin, sisomicin, amikacin and kanamycin are compared for therapeutic use by correlating the in vitro minimal inhibitory concentration with the in vivo concentration of the antibiotic attainable in the serum at half the time intervall between two administrations of the drugs. Using this method of evaluation, E. coli, Enterobacter and sensitive strains of the Klebsiella and Pseudomonas species can be treated in principle equally well with gentamicin, tobramycin and sisomicin, and to a large degree also with amikacin. Gentamicin, sisomicin and amikacin are useful against Serratia infections; but in each case, a higher dosage is needed. Within the family of aminoglycosides, sisomicin has a noteworthy activity against Enterobacter and Proteus species, while tobramycin is most outstanding against pseudomonas strains. Amikacin is especially useful against infections involving Klebsiella, Providencia and Pseudomonas strains with resistance to nearly all antibiotics including the other aminoglycosides.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007709 Klebsiella A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011532 Providencia Gram-negative rods isolated from human urine and feces.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Rosin, and P Naumann, and E Reintjens, and M Köhler
December 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
January 1981, Giornale italiano di chemioterapia,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
September 1978, The Journal of antimicrobial chemotherapy,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
January 2002, Indian journal of cancer,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
May 1986, The Journal of antimicrobial chemotherapy,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
January 1987, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
July 2011, Journal of advanced nursing,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
June 1982, The Journal of allergy and clinical immunology,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
November 1982, La Nouvelle presse medicale,
H Rosin, and P Naumann, and E Reintjens, and M Köhler
January 1984, Current medical research and opinion,
Copied contents to your clipboard!